한의약융합데이터센터
한의약융합데이터 콘텐츠 바로가기
근거중심한의약 DB
Home > 한의약융합데이터센터 > 근거중심한의약 DB
| Title | 불면장애에 대한 천왕보심단의 체계적 문헌 고찰 및 메타분석 연구 |
|---|---|
| Authors | 사공종원, 김동희, 하지원, 조윤송, 김보경 |
| Journal | 동의신경정신과학회지. |
| Year | 2018 |
| Vol (Issue) | 29(4) |
| Page | 267-80. |
| doi | 10.7231/jon.2018.29.4.267 |
| PMID | |
| Url | http://www.ndsl.kr/ndsl/search/detail/article/articleSearchResultDetail.do?cn=JAKO201810063228132 |
| MeSH | |
| Keywords | Primary insomnia; Herbal Medicine (Cheonwangbosim-Dan; Tianwangbuxin-Pellet); Randomized controlled trial; Meta-analysis; Systematic review |
| 한글 키워드 | 일차성 불면증; ; ; 무작위배정 비교 임상시험; 메타 분석; 체계적 문헌고찰 |
| KMCRIC Summary & Commentary |
|
| Korean Study | Y |
| Abstract | Objectives: The objective of this study was to provide clinical evidence to support the use of a herbal medicine (Cheonwangbosim-Dan/Tianwangbuxin-Pellet (TWBXP)) for insomnia.Methods:Randomized controlled trials that verified effects of Herbal Medicine (Cheonwangbosim-Dan, Tianwangbuxin-Pellet) treating primary insomnia were carried out. A literature search of English, Chinese, Korean databases was also performed. The selected literature were assessed by Risk of Bias (RoB).Results:The total number of selected trials was 13 RCTs. Among the 13 RCTs, 10 were meta-analyzed. The Chinese Classification of Mental Disorders-3 (CCMD-3) was frequently used as the diagnostic criteria for interventions during the analysis of the use of herbal medicine (Cheonwangbosim-Dan/Tianwangbuxin-Pellet) for management of primary insomnia. As for outcome measurement, the effective rate was used. From the Meta-analysis of the studies, it was established that the insomnia cure effective rate in the TWBXP group was higher than that in the Western Medicine (WM) group (RR: 1.15, 95% CI: 1.07 to 1.24, p2=33%). Also, the effective rate in the TWBXP+ACU group was significantly different compared to the WM group (RR: 1.32, 95% CI: 1.13 to 1.54, p=0.0004, I2=0%). The quality of the selected RCTs was low.Conclusions:Herbal medicine (Cheonwangbosim-Dan/Tianwangbuxin-Pellet) is effective for treating primary insomnia. It is worth noting that this studies were of relatively poor quality. The sample sizes were also small. Therefore, further investigations into the diagnosis and treatment of insomnia are warranted. |
| 국문초록 | |
| Language | 한국어 |
| 첨부파일 |